Clinical trial
Evaluation of Clinical, Pathologic, and Molecular Determinants of Prognosis and Treatment Response in Patients With Metastatic Malignant Melanoma: A Multicenter Retrospective Study
NCT07256184 is registered in ClinicalTrials.gov with Ankara Etlik City Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Clinical, Pathologic, and Molecular Determinants of Prognosis and Treatment Response in Patients With Metastatic Malignant Melanoma: A Multicenter Retrospective Study
- Lead sponsor
- Ankara Etlik City Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 15, 2022
- Completion date
- December 15, 2024
- Enrollment
- 232 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
metastatic malignant melanoma